Introduction Pulmonary embolism (PE) and deep vein thrombosis (DVT), the two clinical
manifestations of venous thromboembolism (VTE), constitute a major global burden of …

Acutely ill medical patients are at heightened risk for venous thromboembolism, a term that
combines deep vein thrombosis (DVT) and its more severe complication, pulmonary …

Background Emerging clinical evidence has shown that patients with the novel coronavirus
disease-2019 (COVID-19) have complications that include venous thromboembolism (VTE) …

Objective To assess and compare the incidence of venous thromboembolism (VTE) in
patients with rheumatoid arthritis (RA) treated with Janus kinase inhibitors (JAKi), tumour …

Background It is uncertain whether higher doses of anticoagulants than recommended for
thromboprophylaxis are necessary in COVID‐19 patients hospitalized in general wards …

Background Isolated pulmonary embolism (PE) appears to be associated with a specific
clinical profile and sequelae compared to deep vein thrombosis (DVT)-associated PE. The …

Objectives A high rate of thrombotic events has been reported in COVID-19 population. The
study aims to assess the incidence of deep vein thrombosis (DVT) in COVID-19 patients …

Background COVID‐19 patients are considered at high risk of venous thromboembolism
(VTE). The real nature of pulmonary artery occlusions (PAO) in COVID‐19 has been …

Please see the Editorial Comment by Andetta Hunsaker discussing this article. Filling
defects identified in the pulmonary arterial tree are commonly presumed to represent an …

The SARS-CoV-2 virus caused a global pandemic within weeks, causing hundreds of
thousands of people infected. Many patients with severe COVID-19 present with coagulation …